140 related articles for article (PubMed ID: 6244515)
1. Head twitches induced by LSD and quipazine: similarities and differences.
Vetulani J; Bednarczyk B; Reichenberg K; Rokosz A
Neuropharmacology; 1980 Feb; 19(2):155-8. PubMed ID: 6244515
[No Abstract] [Full Text] [Related]
2. The effect of quipazine and LSD on monoamines in the rat striatum.
Miśkiewicz M; Rokosz-Pelc A; Vetulani J
Pol J Pharmacol Pharm; 1979; 31(5):489-92. PubMed ID: 94944
[TBL] [Abstract][Full Text] [Related]
3. Similarities between the pharmacological actions of quipazine and serotonin.
Hong E; Sancilio LF; Vargas R; Pardo EG
Eur J Pharmacol; 1969; 6(3):274-80. PubMed ID: 5816391
[No Abstract] [Full Text] [Related]
4. The actions of neuroleptic drugs and putative serotonin receptor antagonists on LSD and quipazine-induced reductions of brain 5-HIAA concentrations.
Jacoby JH; Poulakos JJ
J Pharm Pharmacol; 1977 Dec; 29(12):771-3. PubMed ID: 22629
[No Abstract] [Full Text] [Related]
5. Head twitches produced by serotonergic drugs and opiates after lesion of the mesostriatal serotonergic system of the rat.
Vetulani J; Byrska B; Reichenberg K
Pol J Pharmacol Pharm; 1979; 31(4):413-23. PubMed ID: 316525
[TBL] [Abstract][Full Text] [Related]
6. Quipazine-induced stimulus control in the rat.
Winter JC
Psychopharmacology (Berl); 1979 Feb; 60(3):265-9. PubMed ID: 108704
[No Abstract] [Full Text] [Related]
7. Drug-induced stimulus control and the concept of breaking point: LSD and quipazine.
Winter JC
Psychopharmacology (Berl); 1981; 72(2):217-8. PubMed ID: 6782615
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects of quipazine in the cat.
Trulson ME; Brandstetter JW; Crisp T; Jacobs BL
Eur J Pharmacol; 1982 Mar; 78(3):295-305. PubMed ID: 6461558
[TBL] [Abstract][Full Text] [Related]
9. Does picrotoxin interact with the 5-HT system in the flexor reflex?
Georgiev VP; Rawlów A
Agressologie; 1978; 19(5):321-4. PubMed ID: 231911
[No Abstract] [Full Text] [Related]
10. Naloxone alters the effects of LSD, DOM and quipazine on operant behavior of rats.
Mokler DJ; Commissaris RL; Henck JW; Rech RH
Pharmacol Biochem Behav; 1984 Sep; 21(3):333-7. PubMed ID: 6593750
[TBL] [Abstract][Full Text] [Related]
11. Rapid development of tolerance upon central injection of LSD.
Carino MA; Horita A
Life Sci; 1977 Jan; 20(1):49-55. PubMed ID: 556794
[No Abstract] [Full Text] [Related]
12. Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity.
Sanders-Bush E; Breeding M
J Pharmacol Exp Ther; 1990 Mar; 252(3):984-8. PubMed ID: 2319481
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of "wet shakes" during morphine abstinence by an antagonist of opiate analgesia.
Vetulani J; Bednarczyk B; Reichenberg K
Eur J Pharmacol; 1978 Aug; 50(3):261-4. PubMed ID: 308460
[TBL] [Abstract][Full Text] [Related]
14. Local cerebral glucose utilisation following indoleamine- and piperazine-containing 5-hydroxytryptamine agonists.
Grome JJ; Harper AM
J Neurochem; 1986 Jan; 46(1):117-24. PubMed ID: 3940273
[TBL] [Abstract][Full Text] [Related]
15. Effects of quipazine on pre- and postsynaptic serotonin receptors: single cell studies in the rat CNS.
Blier P; de Montigny C
Neuropharmacology; 1983 Apr; 22(4):495-9. PubMed ID: 6856049
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the stimulus effects of morphine and lysergic acid diethylamide (LSD).
Hirschhorn ID; Rosecrans JA
Pharmacol Biochem Behav; 1974 May; 2(3):361-6. PubMed ID: 4837907
[No Abstract] [Full Text] [Related]
17. Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions.
White FJ; Appel JB
Science; 1982 Apr; 216(4545):535-7. PubMed ID: 7071600
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazine.
Rokosz-Pelc A; Antkiewicz-Michaluk L; Vetulani J
J Pharm Pharmacol; 1980 Mar; 32(3):220-2. PubMed ID: 6103943
[No Abstract] [Full Text] [Related]
19. Pharmacological profile of a model for central serotonin receptor activation.
Matthews WD; Smith CD
Life Sci; 1980 Apr; 26(17):1397-403. PubMed ID: 6247593
[No Abstract] [Full Text] [Related]
20. Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats: possible involvement of striatal dopaminergic supersensitivity.
Dall'Olio R; Vaccheri A; Gandolfi O; Roncada P; Montanaro N
Pharmacol Biochem Behav; 1988 Dec; 31(4):941-4. PubMed ID: 2908069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
